Literature DB >> 12415609

Anti-androgen treatment of prostatic carcinoma may be a risk factor for development of rheumatoid arthritis.

Janet E Pope1, Mala Joneja, Paul Hong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12415609

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  9 in total

1.  Association of tri-nucleotide (CAG and GGC) repeat polymorphism of androgen receptor gene in Taiwanese women with refractory or remission rheumatoid arthritis.

Authors:  S F Yu; T T Cheng; Y H Hsu; H M Lai; Y C Chen; C K Chiu; K M Lin; C Chang; C J Chen; H Y Kang
Journal:  Clin Rheumatol       Date:  2007-04-13       Impact factor: 2.980

2.  Androgen Deprivation Therapy for Prostate Cancer and the Risk of Rheumatoid Arthritis: A Population-Based Cohort Study.

Authors:  Adi J Klil-Drori; Christina Santella; Koray Tascilar; Hui Yin; Armen Aprikian; Laurent Azoulay
Journal:  Drug Saf       Date:  2019-08       Impact factor: 5.606

Review 3.  Androgen receptor influences on body defense system via modulation of innate and adaptive immune systems: lessons from conditional AR knockout mice.

Authors:  Jiann-Jyh Lai; Kuo-Pao Lai; Weiping Zeng; Kuang-Hsiang Chuang; Saleh Altuwaijri; Chawnshang Chang
Journal:  Am J Pathol       Date:  2012-09-04       Impact factor: 4.307

4.  Susceptibility to autoimmunity and B cell resistance to apoptosis in mice lacking androgen receptor in B cells.

Authors:  Saleh Altuwaijri; Kuang-Hsiang Chuang; Kuo-Pao Lai; Jiann-Jyh Lai; Hung-Yun Lin; Faith M Young; Andrea Bottaro; Meng-Yin Tsai; Wei-Ping Zeng; Hong-Chiang Chang; Shuyuan Yeh; Chawnshang Chang
Journal:  Mol Endocrinol       Date:  2009-01-22

5.  Rapid Anti-Inflammatory Effects of Gonadotropin-Releasing Hormone Antagonism in Rheumatoid Arthritis Patients with High Gonadotropin Levels in the AGRA Trial.

Authors:  Anita Kåss; Ivana Hollan; Morten Wang Fagerland; Hans Christian Gulseth; Peter Abusdal Torjesen; Øystein Torleiv Førre
Journal:  PLoS One       Date:  2015-10-13       Impact factor: 3.240

6.  Association between Androgen Deprivation Therapy and the Risk of Inflammatory Rheumatic Diseases in Men with Prostate Cancer: Nationwide Cohort Study in Lithuania.

Authors:  Mingaile Drevinskaite; Jolanta Dadoniene; Dalia Miltiniene; Ausvydas Patasius; Giedre Smailyte
Journal:  J Clin Med       Date:  2022-04-05       Impact factor: 4.241

7.  High Follicle-Stimulating Hormone Level Associated With Risk of Rheumatoid Arthritis and Disease Activity.

Authors:  Xianhui Zhang; Pengyan Qiao; Qianyu Guo; Zixie Liang; Jie Pan; Fengping Wu; Xuexue Wang; Liyun Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-22       Impact factor: 6.055

8.  Short-term treatment with a gonadotropin-releasing hormone antagonist, cetrorelix, in rheumatoid arthritis (AGRA): a randomized, double-blind, placebo-controlled study.

Authors:  A S Kåss; O T Førre; M W Fagerland; H C Gulseth; P A Torjesen; I Hollan
Journal:  Scand J Rheumatol       Date:  2013-11-01       Impact factor: 3.641

Review 9.  Androgen-Induced Immunosuppression.

Authors:  Melanie R Gubbels Bupp; Trine N Jorgensen
Journal:  Front Immunol       Date:  2018-04-17       Impact factor: 7.561
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.